Development code · Small Molecule
AB1010
AB1010 is a development code for Masitinib, developed by AB Science.
- Status
- Phase 3 for Amyotrophic lateral sclerosis
- Mechanism
- KIT Inhibitor
- Developer
- AB Science
Programs
- Masitinib for Amyotrophic lateral sclerosisPhase 3Active
- Masitinib for Multiple sclerosisPhase 3Suspended
- Masitinib for Alzheimer's diseasePhase 3Suspended
Also known as
- masitinib
- AB 1010
- masitinib mesylate
- Alsitek
- Masivet
- 790299-79-5
- 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide